That's the beauty of debates, you get to hear different points of views, whether one agrees or not,everyone is entitled to their share..
Now, I have some MORE overwhelming evidence that androgens DO in fact target cellular groups,and fatty tissue outside the realm of targeting AR's..There's undeniable facts citing "adipose tissue" is targeting DIRECTLY....
Muscle building,protein synthesis and increased nitrogen
(increased nitrogen balance can be achieve from just diet alone,without AAS) is a completely different topic...Those instances reflect on metabolic rates,macro nutritional intake and the type of workout regiment employed..There's a series of energy conversion methods to exploit adipose tissue,but the topic is HOW AAS solely has direct or indirect targeting properties without being adding to the equation of diet or training...
Now, there will be negligence,ignorance and simply those that will rely or become dependent on AAS to substitute where they lack any actually commitment, know-how or fundamentals on which the primary fat loss principals are based on when it pertains to diet,cardio,training or a health lifestyle all together..
My case and point was to dismiss any talk that AAS does NOT directly effect adipose cells alone....
[h=1]
Effect of testosterone on abdominal adipose tissue in men.[/h]
Rebuffé-Scrive M1, Mårin P, Björntorp P.
[h=3]Author information[/h]
[h=3]Abstract[/h]Recent studies in men have shown that abdominal fat increases with age and decreasing testosterone concentrations. Furthermore, in cell culture, testosterone expresses an increased lipolytic potential and depresses lipoprotein lipase activity (LPL) in adipose cells. These metabolic characteristics are found in abdominal adipose tissue in young men. In order to see whether abdominal fat masses in moderately obese middle-aged men might be diminished by testosterone, this hormone was given either as a single injection (500 mg) or in moderate doses (40 mg X 4) for 6 weeks in an oral preparation, bypassing the liver. When measured 1 week after the single dose, abdominal LPL tended to decrease. After 6 weeks a dramatic decrease of abdominal LPL was found, as well as an increase in the lipolytic responsiveness to norepinephrine, both changes confined solely to the abdominal, and not femoral adipose tissue regions. The waist/hip circumference decreased in 9 out of the 11 examined men. No untoward effects were seen in behavioural variables, blood pressure, triglyceride or cholesterol values, and liver function tests. These preliminary results suggest that administration of testosterone in moderate doses to middle-aged men lead to adaptations of the metabolism of adipose tissue expected to be followed by a diminution of this mass.